LEGAL LANDSCAPE. Sidetracked by side rails

September 2015
Long-Term Living: For the Continuing Care Professional;Sep/Oct2015, Vol. 64 Issue 5, p12
The article discusses that the use of side rails for nursing homes should be the exception rather than the norm subject to a risk-benefit analysis for each resident. Topics covered are the side rail entrapment-related death at Laurelwood Care Center, the recommendation to obtain the informed consent of the resident or authorized individual, and a checklist on the review of the documentation and safety protocols regarding side rails on beds.


Related Articles

  • Risky-drugs list in the spotlight. Rhea, Shawn // Modern Healthcare;8/9/2010, Vol. 40 Issue 32, p14 

    The article reports that healthcare professionals, patient groups and drug manufacturers are concerned about the list of drug-safety requirements issued under the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategies (REMS). They agree that the program is needed to allow...

  • Bedrail entrapment: Is your facility safe? Braun, Julie A.; Capezuti, Elizabeth A. // Nursing Homes: Long Term Care Management;Nov2004, Vol. 53 Issue 11, p56 

    Presents risk management strategies which aimed to reduce bedrail entrapments in various care settings such as nursing homes and hospitals. Members of the Hospital Bed Safety Workgroup; Contents of the "Draft Guidance for Industry and FDA Staff: Hospital Bed System Dimensional Guidance to...

  • The FDA Compliance Program Guidance for GLPS: Inspections I. Kuwahara, Steven S. // Journal of GXP Compliance;Summer2012, Vol. 16 Issue 3, p63 

    This discussion provides information on topics that may be addressed during a good laboratory practice (GLP) inspection. This information is useful to regulatory investigators, industry workers, and internal auditors of facilities and contract organizations. Laboratories are grouped into broad...

  • Storm Clouds? Cloud Computing in a Regulated Environment. Smith, Robert H. // Journal of GXP Compliance;Autumn2011, Vol. 15 Issue 4, p71 

    The article examines the applications of cloud computing in regulated industries. Requirements in technical regulated industries that cloud computing should address are mentioned including access, security, backup, validation, and audits. Examples of models in which cloud computing services may...

  • FDA balks at powdered-glove ban, warning label option blasted.  // Hospital Employee Health;Jun2011, Vol. 30 Issue 6, p61 

    The article reports that the U.S. Food and Drug Administration (FDA) is considering a ban on the use of powder in latex gloves and alternatives while discussing the flak it received for issuing a proposed warning label for powdered gloves. Details on the effects of powdered gloves on patients...

  • Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products. Sharfstein, Joshua M.; Miller, James Dabney; Davis, Anna L.; Ross, Joseph S.; McCarthy, Margaret E.; Smith, Brian; Chaudhry, Anam; Alexander, G. Caleb; Kesselheim, Aaron S. // Journal of Law, Medicine & Ethics;2017 Supplement, Vol. 45, p7 

    Background The U.S. Food and Drug Administration (FDA) traditionally has kept confidential significant amounts of information relevant to the approval or non-approval of specific drugs, devices, and biologics and about the regulatory status of such medical products in FDA’s pipeline....

  • Call for urgency. Lee, Jaimy // Modern Healthcare;11/12/2012, Vol. 42 Issue 46, p17 

    The article reports that hospitals and group purchasing organizations are calling for the rollout of the U.S. Food and Drug Administration's (FDA) proposed rule on a unique device identification (UDI) system. However, manufacturers want more time for the rollout of the system which would require...

  • Providing excellent care for all. Hawes, Richard // Nursing & Residential Care;Aug2015, Vol. 17 Issue 8, p472 

    No abstract available.

  • FDA advisers favor easing rosiglitazone restrictions. Traynor, Kate // American Journal of Health-System Pharmacy;7/15/2013, Vol. 70 Issue 14, p1184 

    The article discusses the developments in the U.S. medical sector as of mid-2013. It cites the move by the Food and Drug Administration's (FDA) Drug Safety and Risk Management and Endocrinologic and Metabolic Drugs advisory committees to support the removal or revision of the risk evaluation and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics